Skip to main content
Top
Published in: Breast Cancer Research 2/2008

01-05-2008 | Poster presentation

'More positive about mammography' – reactions of women to a false positive recall: a qualitative study of women at risk of familial breast cancer

Authors: A Clements, S Tyndel, B Henderson, K Brain, E Watson, J Austoker, the PIMMS Study Management Group

Published in: Breast Cancer Research | Special Issue 2/2008

Login to get access

Excerpt

Annual mammographic screening from the age of 40 is recommended for women in the UK whose family history places them at a lifetime risk of developing breast cancer of ≥ 1:6 [1]. While the clinical benefits of screening younger women at increased risk are not established, emerging evidence suggests screening may lead to increased survival [2]. However, little is understood of the emotional impact of screening on women with a family history. This is particularly important in view of the increased likelihood of recall for further tests in women under 50 years old compared with those over 50 years old [3]. A recent questionnaire study of the psychological impact of mammographic screening on women under 50 years old with a family history of breast cancer showed that, contrary to expectations, women who were recalled for further tests prior to an all-clear result reported significantly more positive feelings post result about screening than women not recalled [4]. This complementary qualitative study explored the value women placed on having joined a programme of regular screening, and sought to understand the reactions of women who had received an initial all-clear result and who had received an all-clear result following further tests. …
Literature
2.
go back to reference Gui GPH, Kadayaprath G, Darhouse N, Self J, Ward A, A'Hern R, Eeles R: Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol. 2006, 32: 719-724. 10.1016/j.ejso.2006.05.002.CrossRefPubMed Gui GPH, Kadayaprath G, Darhouse N, Self J, Ward A, A'Hern R, Eeles R: Clinical outcome and service implications of screening women at increased breast cancer risk from a family history. Eur J Surg Oncol. 2006, 32: 719-724. 10.1016/j.ejso.2006.05.002.CrossRefPubMed
3.
go back to reference Feig SA: Age-related accuracy of screening mammography: how should it be measured?. Radiology. 2000, 214: 633-640.CrossRefPubMed Feig SA: Age-related accuracy of screening mammography: how should it be measured?. Radiology. 2000, 214: 633-640.CrossRefPubMed
4.
go back to reference Tyndel S, Austoker J, Henderson B, et al: What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol. 2007, 25: 3823-3829. 10.1200/JCO.2007.11.0437.CrossRefPubMed Tyndel S, Austoker J, Henderson B, et al: What is the psychological impact of mammographic screening on younger women with a family history of breast cancer? Findings from a prospective cohort study by the PIMMS Management Group. J Clin Oncol. 2007, 25: 3823-3829. 10.1200/JCO.2007.11.0437.CrossRefPubMed
Metadata
Title
'More positive about mammography' – reactions of women to a false positive recall: a qualitative study of women at risk of familial breast cancer
Authors
A Clements
S Tyndel
B Henderson
K Brain
E Watson
J Austoker
the PIMMS Study Management Group
Publication date
01-05-2008
Publisher
BioMed Central
Published in
Breast Cancer Research / Issue Special Issue 2/2008
Electronic ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr1974

Other articles of this Special Issue 2/2008

Breast Cancer Research 2/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine